Skip to main content

Introduction

  • Chapter
  • First Online:
  • 362 Accesses

Abstract

There is an important concept that professionals in oncology must have in mind when we talk about pharmacology in neonates and infants: In this book, as in most references about neonates and infants, the word “neonate” refers to a baby up to 28 days after birth [3]. If a neonate is born prematurely, he can still be called by this terminology—neonate—if he was born more than 28 days previously but his postmenstrual age is ≤42–46 weeks. A baby who was born more than 28 days previously is called an infant. A premature neonate is a baby who was born at <37 weeks of gestational age, and a term neonate is a baby who was born between 37 weeks and 41 weeks plus 6 days of gestational age. When an infant is more than 1 year old, he starts to be called a child. The postmenstrual age is the gestational age plus the postnatal age. The gestational age is the number of weeks from the first day of the mother’s last menstrual period until the baby’s birth, and the postnatal age is the time until birth [4] (Table 1.1).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. US National Library of Medicine: Medline Plus. Medical encyclopedia. http://medlineplus.gov/encyclopedia.html. Accessed 29 Sept 2016.

  2. Taketomo C, Hodding J, Kraus D. Pediatric & neonatal dosage handbook. 21st ed. Hudson: Lexicomp; 2014.

    Google Scholar 

  3. Tayman C, Rayyan M, Allegaert K. Neonatal pharmacology: extensive interindividual variability despite limited size. J Pediatr Pharmacol Ther. 2011;16(3):170–84.

    PubMed  PubMed Central  Google Scholar 

  4. McLeod HL, Relling MV, Crom WR, et al. Disposition of antineoplastic drugs agents in the very young child. Br J Cancer Suppl. 1992;18:S23–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Schmidt CWP, Menezes FG. Drug therapy and interactions in pediatric oncology: a pocket guide. Switzerland: Springer; 2016.

    Google Scholar 

  6. Alamo L, Beck-Popovic M, Gudinchet F, Meuli R. Congenital tumors: imaging when life just begins. Insights Imaging. 2011;2(3):297–308.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2012 incidence and mortality web-based report. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2015. www.cdc.gov/uscs.

  8. Birch JM, Blair V. The epidemiology of infants cancers. Br J Suppl. 1992;18:S2–4.

    CAS  Google Scholar 

  9. Ibagy A, Silva DB, Seiben J, et al. Acute lymphoid leukemia in infants: 20 years of experience. J Pediatr. 2013;89(1):64–9.

    Article  Google Scholar 

  10. Geyer JR, Sposto R, Jennings M, et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children’s Cancer Group. Pediatric Cancer. http://ascopubs.org/doi/full/10.1200/jco.2005.09.095. Accessed 13 Jul 2017.

  11. Gatta G, Botta L, Rossi S, et al. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study. Lancet Oncol. 2014;15:35–47.

    Article  PubMed  Google Scholar 

  12. Yallouros M. Neuroblastom. Kinderkrebsinfo. 2016. www.kinderkrebsinfo.de/sites/kinderkrebsinfo/content/e9031/e10591/e77083/e104562/Neuroblastom-Langinfo12072016_ger.pdf. Accessed 28 Sept 2016.

  13. Office of Statistics and Programming, National Center for Injury Prevention and Control, CDC: 10 leading causes of death by age group. United States 2010. https://www.cdc.gov/injury/wisqars/pdf/10LCID_All_Deaths_By_Age_Group_2010-a.pdf.

  14. van der Linden MH, Creemers S, Pieters R. Diagnosis and management of neonatal leukaemia. Semin Fetal Neonatal Med. 2012;17(4):192–5.

    Article  PubMed  Google Scholar 

  15. Masetti R, Vendemini F, Zama D, Biagi C, Pession A, Locatelli F. Acute myeloid leukemia in infants: biology and treatment. Front Pediatr. 2015;3:37.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Glick RD, Hicks MJ, Nuchtern JG, et al. Renal tumors in infants less than 6 months of age. J Pediatr Surg. 2004;39(4):522–5.

    Article  PubMed  Google Scholar 

  17. Kivelä TT, Hadjistilianou T. Neonatal retinoblastoma. Asia Pac J Ocol Nurs. 2017;4(3):197–204.

    Article  Google Scholar 

  18. Rabin KR, Whitlock JA. Malignancy in children with trisomy 21. Oncologist. 2009;14(2):164–73.

    Article  PubMed  Google Scholar 

  19. Massey GV, Zipursky A, Chang MN, et al. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children’s Oncology Group (COG) study POG-9481. Blood. 2006;107:4606–13.

    Article  CAS  PubMed  Google Scholar 

  20. Klusmann JH, Creutzig U, Zimmerman M, et al. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood. 2008;111(6):2991–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Fukuoka K, Yanagisawa T, Suzuki T, et al. Successful treatment of hemorrhagic congenital intracranial immature teratoma with neoadjuvant chemotherapy and surgery: case report. J Neurosurg Pediatr. 2014;13:38–41.

    Article  PubMed  Google Scholar 

  22. Choudhury SR, Debnath PR, Pant N, Chowdhury L. Congenital immature teratoma of the retroperitoneum. J Neonatal Surg. 2013;2(3):33.

    PubMed  PubMed Central  Google Scholar 

  23. Interiano RB, Davidoff AM. Current management of neonatal neuroblastoma. Curr Pediatr Rev. 2015;11(3):179–87.

    Article  PubMed  Google Scholar 

  24. Veal GJ, Errington J, Hayden J, et al. Carboplatin therapeutic monitoring in preterm and full-term neonates. Eur J Cancer. 2015;51(14):2022–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Schmidt LS, Schüz J, Lähteenmäki P, et al. Fetal growth, preterm birth, neonatal stress and risk for CNS tumors in children: a Nordic population- and register-based case-control study. Cancer Epidemiol Biomarkers Prev. 2010;19(4):1042–52. http://cebp.aacrjournals.org/content/19/4/1042.

    Article  PubMed  Google Scholar 

  26. Isaacs H Jr. Perinatal (fetal and neonatal) astrocytoma: a review. Childs Nerv Syst. 2016;32(11):2085–96.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Duffner PK, Horowitz ME, Krischer JP, et al. The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience. Neuro Oncol. 1999;1(2):152–61. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1920752/pdf/11554387.pdf.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Hunger SP, Loh KM, Baker KS, Schultz KR. Controversies of and unique issues in hematopoietic cell transplantation for infant leukemia. Biol Blood Marrow Transplant. 2009;15(1):79–83.

    Article  PubMed  Google Scholar 

  29. Powis M. Neonatal renal tumors. Early Hum Dev. 2010;86(10):607–12.

    Article  PubMed  Google Scholar 

  30. Ritchey ML, Azizkhan RG, Beckwith JB, Hrabovsky EE, Haase GM. Neonatal Wilms tumor. J Pediatr Surg. 1995;30(6):856–9.

    Article  CAS  PubMed  Google Scholar 

  31. McCahon E, Sorensen PH, Davis JH, Rogers PC, Schultz KR. Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy. Med Pediatr Oncol. 2003;40(5):288–92.

    Article  PubMed  Google Scholar 

  32. Isaacs H Jr. Fetal and neonatal hepatic tumors. J Pediatr Surg. 2007;42(11):1797–803.

    Article  PubMed  Google Scholar 

  33. Isaacs H Jr. Fetal and neonatal cardiac tumors. J Pediatr Cardiol. 2004;25(3):252–73.

    Google Scholar 

  34. Uzun O, Wilson DG, Vujanic GM, Parsons JM, De Giovanni JV. Cardiac tumours in children. Orphanet J Rare Dis. 2007;2(1):11.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Penteado Schmidt, C.W. (2018). Introduction. In: Chemotherapy in Neonates and Infants. Springer, Cham. https://doi.org/10.1007/978-3-319-70591-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-70591-0_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-70590-3

  • Online ISBN: 978-3-319-70591-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics